English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Clinical Trials
ADICON Holdings Limited One of the Top Three ICL Service Providers in China is Successfully Listed on Main Board of SEHK
Jun 30, 2023 14:25 HKT
医疗板块布局正当时,关注新股ICL龙头艾迪康带来的投资机遇
Jun 21, 2023 07:07 HKT
醫療板塊佈局正當時,關注新股ICL龍頭艾迪康帶來的投資機遇
Jun 21, 2023 07:06 HKT
艾迪康宣布于港交所主板上市计划 每股作价12.32港元
Jun 19, 2023 11:39 HKT
艾迪康宣佈於港交所主板上市計劃 每股作價12.32港元
Jun 19, 2023 11:38 HKT
ADICON Announces Proposed Listing on the Main Board of The Stock Exchange of Hong Kong at an Offer Price of HK$12.32 Per Share
Jun 19, 2023 11:37 HKT
Asensus Shares First Quarter Results and Future Plans
Jun 01, 2023 21:40 HKT
2023 ASCO和BIO上的Avance Clinical:早期肿瘤治疗试验越来越复杂,对患者的需求也越来越大
May 30, 2023 11:00 HKT
2023 ASCO和BIO上的Avance Clinical:早期腫瘤治療試驗越來越複雜,對患者的需求也越來越大
May 30, 2023 11:00 HKT
ASCO & BIO 2023에서 아방스 임상: 점점 더 정교해지고 더 많은 환자를 요구하는 초기 단계 종양학 시험
May 30, 2023 11:00 HKT
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients
May 30, 2023 10:00 HKT
아방스 임상, 인생을 변화시키고 생명을 구하는 치료법에 대한 신속한 접근을 위해 글로벌 보건 정상회의 캠페인에 합류
May 25, 2023 16:00 HKT
Avance Clinical 加入全球健康峰会活动,以更快获得改变生活和拯救生命的疗法
May 25, 2023 13:05 HKT
Avance Clinical 加入全球健康峰會活動,以更快獲得改變生活和拯救生命的療法
May 25, 2023 13:05 HKT
Avance Clinical Joins Global Health Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies
May 25, 2023 09:00 HKT
医思健康订立可持续发展表现挂钩银团贷款 开创香港医疗健康市场先河
May 10, 2023 11:54 HKT
醫思健康訂立可持續發展表現掛鈎銀團貸款 開創香港醫療健康市場先河
May 10, 2023 11:53 HKT
EC Healthcare Signs Sustainability-Linked Syndicated Facility, A Ground-breaking Achievement in Hong Kong Healthcare Industry
May 10, 2023 11:52 HKT
Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023
Apr 18, 2023 11:00 HKT
아방스 임상 CEO, 에볼루션 유럽 서밋 2023의 글로벌 바이오파마 패널에 참가
Apr 18, 2023 11:00 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: